A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer

201053 citationsJournal Article

Authors

Good health and well-being

Published in: Investigational New Drugs

Volume 30, Issue 2, pp. 779-786

Field-Weighted Citation Impact: 1.82